Navigation Links
J & J's DePuy Hip Division in $4Bil Settlement, Says Legal-Bay
Date:11/14/2013

NEW YORK, Nov. 14, 2013 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, is reporting -via Bloomberg News- that a landmark settlement has been reached in the extensive DePuy ASR Hip Implant Litigation.  According to sources, the total settlement is approximately $4Bil, which makes it the largest medical device settlement in U.S. history. 

(Logo: http://photos.prnewswire.com/prnh/20131114/PH16982LOGO)

Back in September, Legal-Bay had reported that a settlement of $3Bil was on the horizon, and the average case value for a DePuy Hip requiring revision surgery would be around $300K; it looks as if these figures are pretty accurate.  However, neither side is confirming the details of the reports just yet. 

Legal-Bay has been assisting so many victims of the defective DePuy hip implant device since the start of the litigation in 2010, by providing them with lawsuit pre-settlement funding up to $50,000.00 on their cases.  Legal-Bay will continue to provide lawsuit cash advances, not lawsuit loans, on pending and proposed settled DePuy cases.  To learn more about Legal-Bay's DePuy settlement cash advance program, which is not a settlement loan, you can log on to Legal-Bay's website at: http://lawsuitssettlementfunding.com/depuy-hip-recall-settlement-funding.php

Chris Janish, CEO of Legal-Bay commented, "We always believed that this litigation was one in which J&J would have to step up to the plate, and it seems they now have, with this historic settlement.  The plaintiff's lawyers did a tremendous job getting the company to agree to such a large number now; and to leave the litigation uncapped as more patient's hips fail in the upcoming years.  Most importantly our long suffering clients can now get some of the relief they have long awaited for."  Actual payments do not expect to be disbursed until mid-2014, according to Legal-Bay, if the Judge approves the settlement. 

If you are in need of settlement funding on your DePuy case or in need of speaking to a lawyer about filing a claim on either your DePuy ASR or Pinnacle hip implant, feel free to call Legal-Bay directly at: 877.571.0405 or you may also apply online at: http://lawsuitssettlementfunding.com.

Contact:

Patty Kirby, Head of Client Relations


Ph. 877.571.0405  Email:  info@legal-bay.com       

 


'/>"/>
SOURCE Legal-Bay
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
3. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
4. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
5. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
8. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
9. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
10. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
11. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017  GenomeDx Biosciences today announced that six abstracts ... Prostate Cancer Classifier tests will be presented at the ... Congress held March 24 to 28, 2017 in ... is Europe,s largest urological event ... urological field. The abstract titled "Muscle invasive ...
(Date:3/24/2017)... and GENEVA , March 24, 2017 ... Tuberculosis Day revitalizes efforts to develop sutezolid as effective ... World Tuberculosis Day, TB Alliance and the Medicines Patent ... development of sutezolid, an antibiotic drug candidate which demonstrated ... the development of sutezolid in combination with other TB ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... Technique, Repair Procedure By Technique, By Region, By Country (2016-2021)" ... ... at a CAGR of 13.35% during 2016-2021 The strong ... growth in population with heart disease and rising advances in minimally ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... , ... According to a new study by NCPA Senior Fellow John R. ... rules Congress has directed the CBO to follow. The CBO itself previously recognized Obamacare ... it estimates a reduction in employer-based coverage due to the GOP reform, which is ...
(Date:3/24/2017)... ... March 24, 2017 , ... Shamanic ... Center for Shamanic Healing and Spiritual Awakening, proudly presents her Sacred Peru ... This sacred and spiritual journey during the Summer Solstice will also be ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She ... Record, The majority of cases litigated under ERISA involve claims for long-term disability ...
(Date:3/24/2017)... Texas (PRWEB) , ... March 24, 2017 , ... ... 2017 the year of enhancements, upgrading their training and leads programs. , In ... University. Reserved for elite sales agents, Performance Partners is designed to teach how ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... “Vintage and ... a retired minister and college Bible teacher residing in North Carolina with his wife, ... who have blessed them with six grandchildren. David is also the author of “Shadow ...
Breaking Medicine News(10 mins):